William C. Olson, VP, Research & Development at PROGENICS PHARMACEUTICALS INC (PGNX), sold 1,000 shares at $21.62 ($22K) on 2006-06-20, disclosed to the SEC on 2006-06-22.
Scheduled sale ($22k) by VP, Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PGNX | SELL | 2009-06-24 | $12K | — | Filing → |
| PGNX | SELL | 2007-12-05 | $76K | — | Filing → |
| PGNX | SELL | 2006-05-08 | $336K | — | Filing → |